Westchester Capital Management (Nebraska)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.76M Sell
99,190
-2,132
-2% -$172K 1.4% 21
2026
Q1
$8.78M Buy
101,322
+1,865
+2% +$179K 1.77% 20
2025
Q4
$9.55M Buy
99,457
+940
+1% +$91.3K 1.98% 21
2025
Q3
$9.38M Sell
98,517
-437
-0.4% -$40.2K 2.02% 20
2025
Q2
$8.63M Buy
98,954
+500
+0.5% +$42.4K 2.03% 21
2025
Q1
$8.85M Buy
98,454
+12,974
+15% +$1.16M 2.2% 20
2024
Q4
$6.83M Sell
85,480
-1,653
-2% -$143K 1.72% 22
2024
Q3
$7.84M Sell
87,133
-148
-0.2% -$12.4K 1.91% 21
2024
Q2
$6.87M Sell
87,281
-348
-0.4% -$28.5K 1.73% 23
2024
Q1
$7.64M Sell
87,629
-635
-0.7% -$54.2K 1.92% 23
2023
Q4
$7.27M Sell
88,264
-1,124
-1% -$85.7K 1.96% 23
2023
Q3
$7M Buy
89,388
+1,089
+1% +$91.2K 2.01% 23
2023
Q2
$7.78M Buy
88,299
+687
+0.8% +$59.1K 2.17% 22
2023
Q1
$7.06M Buy
87,612
+839
+1% +$68.4K 2.03% 24
2022
Q4
$6.74M Sell
86,773
-384
-0.4% -$31.1K 1.98% 22
2022
Q3
$7.04M Sell
87,157
-130
-0.1% -$11.7K 2.27% 23
2022
Q2
$7.83M Buy
87,287
+1,350
+2% +$137K 2.39% 23
2022
Q1
$9.54M Buy
85,937
+890
+1% +$94K 2.46% 24
2021
Q4
$8.8M Buy
85,047
+2,849
+3% +$330K 2.25% 23
2021
Q3
$10.3M Buy
82,198
+1,045
+1% +$135K 2.87% 22
2021
Q2
$10.1M Buy
81,153
+630
+0.8% +$79.1K 2.83% 22
2021
Q1
$9.51M Sell
80,523
-448
-0.6% -$52.5K 2.75% 22
2020
Q4
$9.48M Sell
80,971
-544
-0.7% -$59.9K 2.99% 21
2020
Q3
$8.47M Buy
81,515
+1,566
+2% +$157K 3.01% 21
2020
Q2
$7.33M Buy
+79,949
New +$7.67M 2.76% 22

Other funds holding MDT

Westchester Capital Management (Nebraska)'s MDT Position: Q2 2026 in Review

Westchester Capital Management (Nebraska) reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $172K and leaving 99,190 shares worth $7.76M. The position accounts for 1.4% of the portfolio, ranked #21.

Westchester Capital Management (Nebraska) first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.3M in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Westchester Capital Management (Nebraska) held 99,190 shares of Medtronic worth $7.76M as of Q2 2026.
  • Westchester Capital Management (Nebraska) sold 2,132 Medtronic shares in Q2 2026, an estimated $172K.
  • Medtronic made up 1.4% of Westchester Capital Management (Nebraska)'s portfolio in Q2 2026, its #21 holding.
  • Westchester Capital Management (Nebraska) first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
  • Westchester Capital Management (Nebraska)'s Medtronic position peaked at $10.3M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Westchester Capital Management (Nebraska)'s 13F filing for Q2 2026, filed 23 Jul 2026.